Specialized Medical Company: Q1 2026 delivered strong revenue and profit growth, supported by outpatient and acute care expansion

About this update from Specialized Medical Company

Q1 2026 saw 3.3% YoY net revenue growth and 9.8% higher net profit, driven by outpatient and acute care expansion, margin improvement, and operational efficiency. Strategic projects and new clinics support a positive FY 2026 outlook, with continued investment and strong balance sheet.Original document: This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

View stock analysis, news, and events for Specialized Medical Company